Skip to main content
. 2020 Feb;20(1):63–69. doi: 10.17305/bjbms.2019.4297

FIGURE 5.

FIGURE 5

Kaplan–Meier analysis of overall survival in patients with IDH1/2 wild-type primary GB in relation to MALAT1 expression. Patients with IDH1/2 wild-type primary GB and upregulated MALAT1 expression had a significantly shorter survival time compared with those with downregulated MALAT1 expression. IDH: Isocitrate dehydrogenase, GB: Glioblastoma, MALAT1: Metastasis associated lung adenocarcinoma transcript-1.